DeepMed Research

Rigshospitalet

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Private

Established: 1757-03-30

Employees: 10K

Market Cap: -

Website: http://www.rigshospitalet.dk

Clinical Trials

SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting

Not Applicable

Completed

Conditions: Ischaemic Heart Disease

Interventions: Other: Comprehensive phase one rehabilitation

First Posted Date: 2014-11-14

Last Posted Date: 2017-01-02

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 326

Registration Number: NCT02290262

Locations: 🇩🇰
Hjertecentret, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, OE, Denmark

Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method

Completed

Conditions: Measurements of Areas of Secondary Hyperalgesia

First Posted Date: 2014-11-07

Last Posted Date: 2014-11-07

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 23

Registration Number: NCT02286037

The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids

Completed

Conditions: Opioids
Immune System
Endocrine System
Quality of Life
Pain

First Posted Date: 2014-10-28

Last Posted Date: 2023-03-20

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 82

Registration Number: NCT02277080

European Trial of Pirfenidone in BOS, A European Multi-center Study

Phase 2

Completed

Conditions: Disorder Related to Lung Transplantation
CLAD, Bronchiolitis Obliterans

Interventions: Drug: Placebo
Drug: Pirfenidone

First Posted Date: 2014-10-13

Last Posted Date: 2020-01-18

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 90

Registration Number: NCT02262299

Locations: 🇳🇱
Groningen University Medical Center, Lung Transplant Team, Groningen, Netherlands
🇩🇪
Medizinische Hochschule Hannover, Klinik für Pneumonologie, Hannover, Germany
🇩🇪
Klinikum Grosshadern, Division of Pulmonary Diseases, Munich, Germany

and more 6 locations

Optimal Cardiac Resynchronization Therapy Pacing Rate

Early Phase 1

Completed

Conditions: Bi-ventricular Pacing
Heart Failure
Sympathetic Activity
Quality of Life
Cardiac Resynchronization Therapy

Interventions: Procedure: DDD-60
Procedure: DDD-80

First Posted Date: 2014-10-07

Last Posted Date: 2014-10-07

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 15

Registration Number: NCT02258061

Locations: 🇩🇰
Rigshospitalet, University hospital of Copenhagen, Copenhagen, Denmark

The Features Behind the Beneficial Effects of Interval-walking

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: IW3
Behavioral: IW1
Behavioral: Control

First Posted Date: 2014-10-06

Last Posted Date: 2015-10-29

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 12

Registration Number: NCT02257190

Locations: 🇩🇰
Center for Physical Activity Research (CFAS), Copenhagen, Denmark

SIMOX - Induction of Oxidative Stress

Phase 2

Completed

Conditions: Oxidative Stress

Interventions: Drug: Placebo
Drug: Simvastatin

First Posted Date: 2014-10-03

Last Posted Date: 2015-03-10

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 40

Registration Number: NCT02256254

Locations: 🇩🇰
Department of Clinical Pharmacology, Copenhagen, Denmark

Prediction of Pain After Total Knee Arthroplasty

Completed

Conditions: Knee Osteoarthritis

First Posted Date: 2014-10-02

Last Posted Date: 2015-09-23

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 60

Registration Number: NCT02254499

Locations: 🇩🇰
Gentofte Hospital, Hellerup, Denmark

Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty

Phase 2

Completed

Conditions: Knee Joint Osteoarthrosis
Hyperalgesia
Severe Movement Related Pain

Interventions: Drug: Methylprednisoloneacetate
Drug: Lidocaine
Other: sodium chloride

First Posted Date: 2014-10-01

Last Posted Date: 2016-06-06

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 48

Registration Number: NCT02253966

Locations: 🇩🇰
Gentofte Hospital, Hellerup, Denmark

Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)

Phase 4

Completed

Conditions: Endothelial Dysfunction
Aortic Aneurysm, Thoracic

Interventions: Biological: Fresh frozen plasma
Drug: OctaplasLG®

First Posted Date: 2014-10-01

Last Posted Date: 2016-12-20

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 44

Registration Number: NCT02253082

Locations: 🇩🇰
Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy